Last updated: April 25, 2026
Who Supplies Seladelpar Lysine for Drug Development and Commercial Supply?
What is seladelpar lysine in the supply chain?
Seladelpar lysine is the lysine salt form of seladelpar (a peroxisome proliferator-activated receptor delta, PPARδ agonist). In practice, commercial and development supply is split across: (1) active pharmaceutical ingredient (API) manufacture (seladelpar base and/or seladelpar lysine), (2) salt formation and isolation to the lysine salt, and (3) finished dosage manufacturing (e.g., capsule/tablet fill-finish).
This answer is constrained to supplier identifications that can be stated with high confidence from publicly citable patent and regulatory records. If a supplier is not explicitly attributable in those records, it is not listed.
Who manufactures seladelpar (API) and/or seladelpar lysine?
No supplier roster can be produced here with the required level of factual specificity. Public domain sources commonly reference the drug’s originator and trial network but do not consistently name contract manufacturing organizations (CMOs), salt-formulation suppliers, or API vendors for seladelpar lysine in a way that supports a complete and accurate “suppliers” list.
What roles do suppliers typically play for seladelpar lysine?
Even without supplier names, the operational supply structure for a lysine salt drug typically follows this pattern:
| Supply role |
What the supplier delivers |
Typical technical scope |
| API manufacturer |
Seladelpar base and/or seladelpar lysine API |
Synthetic intermediates, final API isolation, impurity control |
| Salt formation supplier |
Seladelpar lysine (solid form) from seladelpar base |
Salt screening, crystallization, polymorph and hydrate control |
| Formulation and fill-finish CMO |
Dosage form using seladelpar lysine |
Milling, blending, tablet/capsule compression, packaging |
What can be stated from patent-grade information?
Patent literature for seladelpar and its salts often identifies synthesis routes and salt-forming components (e.g., lysine) but frequently does not name commercial manufacturing suppliers. Where names are present, they usually reflect process inventors or corporate assignees rather than contract suppliers.
Supply-screening shortcuts that actually map to names (without guessing)
A defensible way to identify “suppliers for seladelpar lysine” is to read and extract the named manufacturers from:
- Regulatory submission chemistry sections that name API and dosage-site manufacturers
- Patent examples that name assignees and sometimes specific third parties in experimental scale-up
- Global procurement databases that disclose site-specific manufacturing, labeling, or batch-release sites
Under the constraint that only fully citable supplier names can be reported, those records are not available in this prompt context.
Key Takeaways
- “Suppliers for seladelpar lysine” cannot be listed accurately from the information provided here.
- Seladelpar lysine supply is typically divided into API production, salt formation, and finished dosage manufacturing, but supplier names require explicit citable records that are not included.
- Any supplier list produced without those records would be speculative and is excluded.
FAQs
-
Is seladelpar lysine the same as seladelpar?
No. Seladelpar lysine is a lysine salt form of seladelpar, which changes solid-state properties and manufacturing considerations.
-
What types of vendors supply a lysine salt drug?
API manufacturers (seladelpar), salt formers (seladelpar lysine isolation), and formulation/fill-finish CMOs for the final dosage form.
-
Why don’t patents always list suppliers?
Patent examples focus on synthesis, not commercial sourcing, and often identify assignees rather than contract manufacturing organizations.
-
What documents usually name the real suppliers?
Regulatory submission manufacturing site sections and certain batch-release or labeling-linked records that explicitly identify companies and facilities.
-
Can a generic “API supplier” be used for seladelpar lysine?
Not reliably, because lysine salt formation and solid-state control can be site- and process-specific, so sourcing must match salt-form capability and specs.
References
[1] No citable supplier-specific sources were provided in the prompt context.
